J.B. Chemicals & Pharmaceuticals Ltd - Comparative Business Analysis Snapshot
Business Description J.B. Chemicals & Pharmaceuticals Ltd. The Group's principal activity is to manufacture and market pharmaceutical formulations, herbal remedies, bulk drugs, intermediates and radio-diagnostics. The Group's Research and development team focuses on development of Novel Drug Delivery Systems and regulatory filings for its generic drugs, formulations and active pharmaceutical ingredients in the regulated, semi-regulated as well as non-regulated markets. The Group's brands include Metrogyl, Rantac, Nicardia Retard, OF OD (antibiotic), Vasolip, Moviz and Cefjoy Tablets. Its plants are located at Maharashtra and Gujarat. The Group exports its products to Sri Lanka, Africa and South East Asia.
Competitor Analysis
This analysis compares J.B. Chemicals & Pharmaceuticals Ltd with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for?Click here for more browsing options.
* If a currency is not selected, the report will be delivered in the local currency of the company ** Full access limits users to 500 reports per month
Web site and selected data copyright 2008 The Winthrop Corporation. All rights reserved. Selected data copyright 2008, "Worldscope/Disclosure, L.L.C., a Primark affiliate." All rights reserved.